West Pharmaceutical Services Inc. Stock Falls 4.3%, Underperforms Competitors

Dow Jones
05-15

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. slipped 4.3% to $206.69 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.1% to 5,892.58 and the Dow Jones Industrial Average falling 0.2% to 42,051.06.

This was the stock's second consecutive day of losses.

West Pharmaceutical Services Inc. closed 42.3% below its 52-week high of $358.22, which the company achieved on May 15th.

The stock underperformed when compared to some of its competitors, as Abbott Laboratories fell 0.4% to $128.56, Becton Dickinson & Co. fell 2.5% to $171.02, and Baxter International Inc. fell 2.66% to $30.32.

Trading volume totaled 660,721, compared to the 50-day average of 958,759.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 14, 2025 16:34 ET (20:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10